{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:04:26Z","timestamp":1774883066034,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mvr.2021.104233","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T23:42:59Z","timestamp":1629157379000},"page":"104233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p\/VEGFA"],"prefix":"10.1016","volume":"138","author":[{"given":"Shiliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2021.104233_bb0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/JME-18-0098","article-title":"LncRNA NEAT1 promotes inflammatory response and induces corneal neovascularization","volume":"61","author":"Bai","year":"2018","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.mvr.2021.104233_bb0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15384101.2019.1578143","article-title":"lncRNA MIAT suppression alleviates corneal angiogenesis through regulating miR-1246\/ACE","volume":"18","author":"Bai","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mvr.2021.104233_bb0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Current Opinion in Ophthalmology"},{"key":"10.1016\/j.mvr.2021.104233_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: An anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Survey of Ophthalmology"},{"key":"10.1016\/j.mvr.2021.104233_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: An anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Survey of Ophthalmology"},{"key":"10.1016\/j.mvr.2021.104233_bb0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3892\/mmr.2021.11877","article-title":"Inhibition of PDGF-BB reduces alkali-induced corneal neovascularization in mice","volume":"23","author":"Chen","year":"2021","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.mvr.2021.104233_bb0035","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/ICO.0b013e31825ec407","article-title":"Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab","volume":"32","author":"Chu","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.mvr.2021.104233_bb0040","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.18240\/ijo.2019.12.19","article-title":"LncRNAs in ocular neovascularizations","volume":"12","author":"Ciss\u00e9","year":"2019","journal-title":"International Journal of Ophthalmology"},{"key":"10.1016\/j.mvr.2021.104233_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2174\/1381612826666191227154009","article-title":"Pathophysiological functions of the lncRNA TUG1","volume":"26","author":"Guo","year":"2020","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.mvr.2021.104233_bb0050","first-page":"2719","article-title":"Transient downregulation of microRNA-206 protects alkali burn injury in mouse cornea by regulating connexin 43","volume":"8","author":"Li","year":"2015","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/j.mvr.2021.104233_bb0055","first-page":"7439","article-title":"LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA-21\/PTEN axis","volume":"22","author":"Li","year":"2018","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/j.mvr.2021.104233_bb0060","article-title":"Long noncoding RNA TUG1\/miR-29c axis affects cell proliferation, invasion, and migration in human pancreatic cancer","volume":"6857042\u20136857042","author":"Lu","year":"2018","journal-title":"Disease Markers"},{"key":"10.1016\/j.mvr.2021.104233_bb0065","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)","volume":"91","author":"Manzano","year":"2007","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.mvr.2021.104233_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.04322.x","article-title":"Prevention and treatment of systemic glucocorticoid side effects","volume":"49","author":"Moghadam-Kia","year":"2010","journal-title":"International Journal of Dermatology"},{"key":"10.1016\/j.mvr.2021.104233_bb0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jtos.2019.04.002","article-title":"MicroRNAs in the cornea: Role and implications for treatment of corneal neovascularization","volume":"17","author":"Mukwaya","year":"2019","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.mvr.2021.104233_bb0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/eop.13.8","article-title":"Corneal neovascularization: a review of the molecular biology and current therapies","volume":"8","author":"Rolfsen","year":"2013","journal-title":"Expert Rev Ophthalmol."},{"key":"10.1016\/j.mvr.2021.104233_bb0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.mvr.2021.104233_bb0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and upcoming therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.mvr.2021.104233_bb0095","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.3390\/ijms21134758","article-title":"Lipid signaling in ocular neovascularization","volume":"21","author":"Terao","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.mvr.2021.104233_bb0100","article-title":"Notch signaling pathway is involved in bFGF-induced corneal lymphangiogenesis and hemangiogenesis","volume":"9613923","author":"Xie","year":"2019","journal-title":"Journal of Ophthalmology"},{"key":"10.1016\/j.mvr.2021.104233_bb0105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ijcard.2014.09.204","article-title":"MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation","volume":"177","author":"Yang","year":"2014","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.mvr.2021.104233_bb0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cub.2005.02.027","article-title":"The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina","volume":"15","author":"Young","year":"2005","journal-title":"Current Biology"},{"key":"10.1016\/j.mvr.2021.104233_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.exer.2017.12.001","article-title":"Epithelium-derived miR-204 inhibits corneal neovascularization","volume":"167","author":"Zhang","year":"2018","journal-title":"Experimental Eye Research"},{"issue":"6","key":"10.1016\/j.mvr.2021.104233_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12832","article-title":"MiR-505 promotes M2 polarization in choroidal neovascularization model mice by targeting transmembrane protein 229B","volume":"90","author":"Zhao","year":"2019","journal-title":"Scandinavian Journal of Immunology"}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286221001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:01:35Z","timestamp":1758434495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286221001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":24,"alternative-id":["S0026286221001035"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104233","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knockdown of lncRNA TUG1 suppresses corneal angiogenesis through regulating miR-505-3p\/VEGFA","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2021.104233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104233"}}